COVID-19 RELATED STUDY INVOLVING DOGS

NIH RePORTER · NIH · N01 · $597,893 · view on reporter.nih.gov ↗

Abstract

Human recombinant ACE2 will be administered to dogs as an aerosol to assess potential toxicities. Results will be used to support an Investigational New Drug Application with the FDA for a clinical trial addressing patients with COVID-19 infection.

Key facts

NIH application ID: 10269151
Project number: 75N91019D00013-0-759102000002-1
Recipient: IIT RESEARCH INSTITUTE
Principal Investigator: DAVID MCCORMICK
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $597,893
Award type: —
Project period: 2020-09-16 → 2021-03-15